
DNASE1L3 as a Prognostic Biomarker Associated with Immune Cell Infiltration in Cancer
Author(s) -
Zenghua Deng,
Mengmeng Xiao,
Dexiao Du,
Nan Luo,
Dongfang Liu,
Tingting Liu,
Dongbo Lian,
Jirun Peng
Publication year - 2021
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s294332
Subject(s) - medicine , adenocarcinoma , hepatocellular carcinoma , immune system , tissue microarray , lung cancer , immunohistochemistry , breast cancer , cancer research , carcinoma , biomarker , cancer , pathology , oncology , biology , immunology , biochemistry
Deoxyribonuclease 1 like 3 (DNASE1L3) is critically involved in apoptosis and immune response, however, its role in cancer has yet to be deciphered. We aimed to explore the prognostic value of DNASE1L3 across a series of malignancies.